Health & Pharma

Pennsylvania Attorney General Michelle A. Henry last month.

Pa., N.J. join settlement with generic drug firms accused of price-fixing. Consumers may be eligible for refunds.

Generic drugmakers Heritage Pharmaceuticals Inc. and Apotex Corp. will pay a combined $49.1 million as part of the agreements with 50 states and territories, officials said.

Dennis Williams (left), Senior Vice President, Late Stage Development and Mark Stielow (right), Vice President U.S. Manufacturing and Technical Operations at Adaptimmune in the Navy Shipyard, Thursday, Sept. 12, 2024. After getting approval for a new type of cancer therapy (Tecelra) that uses the immune system to target cancer cells, the company is gearing up for patient orders to arrive.

Health

A Navy Yard biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients.

Health & Pharma

High insulin prices spur a federal lawsuit against three pharmacy benefit managers

Researchers working in the Radiant Biotherapeutics lab in Toronto. The company — whose CEO is based in West Chester, Pa. — has received $35 million in new financing, including from the Gates Foundation.

Health

The Gates Foundation is part of $35 million in financing going to a Philly-area biotech

Adaptimmune ribbon-cutting ceremony at the Navy Yard headquarters in 2018. On Thursday, the company announced that the U.S. Food and Drug Administration had approved its first-of-its-kind treatment for a rare type of cancer found in muscle and ligaments.

Health

Pa., N.J. join settlement with generic drug firms accused of price-fixing. Consumers may be eligible for refunds.

A Navy Yard biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients.

High insulin prices spur a federal lawsuit against three pharmacy benefit managers

The Gates Foundation is part of $35 million in financing going to a Philly-area biotech

A Philly biotech has earned FDA approval for the first-of-its-kind cancer therapy